Stroke rate after external fractionated radiotherapy for benign meningioma
- PMID: 33394261
- DOI: 10.1007/s11060-020-03678-3
Stroke rate after external fractionated radiotherapy for benign meningioma
Abstract
Purpose: Patients with a benign meningioma often have a long survival following the treatment of their meningioma. Since radiotherapy is frequently part of the treatment, long-term side effects are of considerable concern. A controversial long-term side effect of radiotherapy is stroke. Due to its severity, it is important to know the frequency of this side effect. The aim of this study was to assess the stroke incidence and risk factors among patients receiving radiotherapy for their benign meningioma.
Methods: We performed a retrospective database study of patients who underwent primary or adjuvant radiotherapy for their benign meningioma at University Hospitals Leuven from January 2003 to December 2017.
Results: We included 169 patients with a median age of 51 years (range 22-84). Every patient received fractionated radiotherapy using photons with a median dose of 56 Gy (range 54-56) in fractions of 2 Gy (range 1.8-2). The median follow-up was 5.3 years (range 0.1-14). The cumulative stroke incidence function showed an incidence of 11.6% after 9 years of follow-up, translating to a stroke incidence per year of 1.29%. We found two significant risk factors for stroke: medically treated arterial hypertension (p = 0.005) and history of previous stroke or transient ischemic attack (p < 0.001). 5-year local control and overall survival rates were respectively 97.4% and 91.2%. Other late grade III/IV toxicities occurred in 16.0% (27/169) of patients.
Conclusion: Our study shows a higher incidence of stroke in patients who received radiotherapy for their benign meningioma compared to the general population.
Keywords: Benign meningioma; Fractionated radiotherapy; Late toxicity; Photon beam radiotherapy; Stroke.
References
-
- Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307–314. https://doi.org/10.1007/s11060-010-0386-3 - DOI - PubMed - PMC
-
- Whittle IR, Smith C, Navoo P, Collie D (2004) Meningiomas. Lancet 363:1535–1543. https://doi.org/10.1016/S0140-6736(04)16153-9 - DOI - PubMed
-
- Mendenhall WM, Morris CG, Amdur RJ, Foote KD, Friedman WA (2003) Radiotherapy alone or after subtotal resection for benign skull base meningiomas. Cancer 98:1473–1482. https://doi.org/10.1002/cncr.11645 - DOI - PubMed
-
- Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J (2006) Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas. Strahlentherapie und Onkol 182:635–640. https://doi.org/10.1007/s00066-006-1548-2 - DOI
-
- Soldà F, Wharram B, De Ieso PB, Bonner J, Ashley S, Brada M (2013) Long-term efficacy of fractionated radiotherapy for benign meningiomas. Radiother Oncol 109:330–334. https://doi.org/10.1016/J.RADONC.2013.10.006 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical